Avego Bioscience Capital is an investment firm.
Avego Bioscience Capital is an investment firm.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 3, 2021
Antios Therapeutics
|
Series B | $75M | Biopharma | — |
Jun 14, 2021
Ribon Therapeutics
|
Series C | $65M | Biotechnology | — |
Mar 3, 2021
Caribou Biosciences
|
Series C | $115M | Biotechnology | — |
Avego Bioscience Capital has had 1 exits. Avego Bioscience Capital most notable exits include Caribou Biosciences
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jul 23, 2021 | Caribou Biosciences | IPO | Biotechnology | Detail |